Currently predicting for Tue, 26 Sep 2023

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 35.72 1.29 %
R2 35.51 0.690 %
R1 35.38 0.322 %
Current price: 35.27
Support S1 34.96 -0.87 %
S2 34.83 -1.24 %
S3 34.62 -1.83 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 40.43 14.63 %
R2 38.99 10.55 %
R1 38.84 10.12 %
Current price 35.27
Support S1 35.16 -0.312%
S2 0 .
S3 0 .

GLPG Predictions History

3 years ago
sander7100 yo bro predicted that GLPG for 2020-08-21 is going $192.15 (40.09%)

3 years ago
JS predicted that GLPG for 2020-08-21 is going $146.03 (6.47%)

3 years ago
2poJeff predicted that GLPG for 2020-08-21 is going $140.99 (-1.76%)

4 years ago
GoldenNugget predicted that GLPG for 2019-05-07 is going $120.26 (4.76%)

4 years ago
GoldenNugget predicted that GLPG for 2019-05-06 is going $108.22 (-5.86%)

4 years ago
NameNotImportant predicted that GLPG for 2019-04-23 is going $113.69 (-1.14%)

4 years ago
PumpTheseNumbers predicted that GLPG for 2019-04-03 is going $118.14 (-3.56%)

4 years ago
JS predicted that GLPG for 2019-04-03 is going $118.37 (-3.37%)

4 years ago
Mars.Wong.104328 predicted that GLPG for 2019-04-03 is going $110.11 (-10.11%)

Rank:

6 years ago
Joost.Piepers.9742 predicted that GLPG for 2017-07-20 is going $74.00 (-2.84%)

Rank:
Click to get the best stock tips daily for free!

About Galapagos NV

Galapagos NV Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative colitis, small bowel CD, fistulizing CD, ankylosing spondylitis, psoriatic arthritis, and uveitis. The compan... GLPG Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT